|
immune effector process
|
GO:0002252 |
321 |
0.241
|
Mouse |
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.217
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.190
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.183
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.153
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.152
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.136
|
Mouse |
|
sodium ion export
|
GO:0071436 |
2 |
0.131
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.122
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.121
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.118
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.116
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.114
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.112
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.110
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.109
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.107
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.107
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.100
|
|
|
sodium ion export from cell
|
GO:0036376 |
1 |
0.098
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.088
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.088
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.083
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.083
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.081
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.081
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.080
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.076
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.074
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.072
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.071
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.068
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.067
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.067
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.066
|
Mouse |
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.065
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.064
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.064
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
12 |
0.064
|
Mouse |
|
bone development
|
GO:0060348 |
120 |
0.063
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.062
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.061
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.061
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.061
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.061
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.060
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.059
|
|
|
gland development
|
GO:0048732 |
330 |
0.058
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.057
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.057
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.057
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.057
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.057
|
Human |
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.056
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.056
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.056
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.055
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.055
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.054
|
|
|
wound healing
|
GO:0042060 |
157 |
0.054
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.054
|
Human |
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.054
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.054
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.052
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.052
|
|
|
organ growth
|
GO:0035265 |
117 |
0.051
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.051
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.051
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.050
|
|
|
cell growth
|
GO:0016049 |
130 |
0.049
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.049
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.048
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.048
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.048
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.048
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.047
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.047
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.046
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.046
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.046
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.046
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.046
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.046
|
Mouse |
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.046
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.046
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.045
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.045
|
Mouse |
|
innate immune response
|
GO:0045087 |
157 |
0.045
|
Mouse |
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.045
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.045
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.044
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.043
|
|
|
cation transport
|
GO:0006812 |
399 |
0.043
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.043
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.043
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.043
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.043
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.042
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.042
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.041
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.041
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.041
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.041
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.041
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.041
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.041
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.040
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.039
|
Human |
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.039
|
|
|
lung development
|
GO:0030324 |
164 |
0.039
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.039
|
Mouse |
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.039
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.039
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.039
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.038
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.038
|
Mouse |
|
respiratory system development
|
GO:0060541 |
190 |
0.038
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.038
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.038
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.037
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.037
|
|
|
kidney development
|
GO:0001822 |
213 |
0.037
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.036
|
|
|
appendage development
|
GO:0048736 |
166 |
0.036
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.036
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.036
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.035
|
|
|
regionalization
|
GO:0003002 |
337 |
0.035
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.035
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.035
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.035
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.035
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.034
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.034
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.034
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.034
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.033
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.033
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.033
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.033
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.033
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.033
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.032
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.032
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.032
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.032
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.032
|
|
|
cell division
|
GO:0051301 |
120 |
0.032
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.032
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.032
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.032
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.032
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.031
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.031
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.031
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.031
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.031
|
Mouse |
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.031
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.031
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.031
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.031
|
|
|
rna interference
|
GO:0016246 |
2 |
0.031
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.031
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.030
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.030
|
|
|
ossification
|
GO:0001503 |
216 |
0.030
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.030
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.030
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.030
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.030
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.030
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.030
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.029
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
37 |
0.029
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.029
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.029
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.029
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.029
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.029
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.028
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.028
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.028
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.028
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.028
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.028
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.028
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.027
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.027
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.027
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.027
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.027
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.027
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.027
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.027
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.027
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.027
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.026
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.026
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.026
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.026
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.026
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.026
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.026
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.026
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.026
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.026
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.025
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.025
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.025
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.025
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.025
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.025
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.025
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.025
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.025
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.025
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.025
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.025
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.024
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.024
|
Mouse |
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.024
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.024
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.024
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.024
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.024
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.024
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.024
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.024
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.024
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.024
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.024
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.024
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.024
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.024
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.024
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.024
|
Human |
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.024
|
|
|
regulation of sodium ion transmembrane transporter activity
|
GO:2000649 |
9 |
0.023
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.023
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.023
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.023
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.023
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.023
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.023
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.023
|
Mouse |
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.023
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.023
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.023
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.023
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.023
|
|
|
killing of cells of other organism
|
GO:0031640 |
13 |
0.023
|
Mouse |
|
protein secretion
|
GO:0009306 |
111 |
0.022
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.022
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.022
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.022
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.022
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.022
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.022
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.022
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.022
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.022
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.022
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.022
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.022
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.022
|
Mouse |
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.022
|
|
|
corticotropin hormone secreting cell differentiation
|
GO:0060128 |
3 |
0.022
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.022
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.022
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.022
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.021
|
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.021
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.021
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.021
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.021
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.021
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.021
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.021
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.020
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.020
|
|
|
segmentation
|
GO:0035282 |
93 |
0.020
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.020
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.020
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.020
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.020
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.020
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.020
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.020
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.020
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.020
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.020
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.020
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.020
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.020
|
|
|
hypotonic response
|
GO:0006971 |
3 |
0.020
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.020
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.020
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.020
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.020
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.020
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.019
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.019
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.019
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.019
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.019
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.019
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.019
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.019
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.019
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.019
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.019
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.019
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.019
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.019
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.019
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.019
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.019
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.019
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.019
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.018
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.018
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.018
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.018
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.018
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.018
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.018
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.018
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.018
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.018
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.018
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.018
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.018
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.018
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.018
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.018
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.018
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.018
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.018
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.018
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.018
|
|
|
cell killing
|
GO:0001906 |
67 |
0.017
|
Mouse |
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.017
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.017
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.017
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.017
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.017
|
|
|
fluid transport
|
GO:0042044 |
14 |
0.017
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.017
|
|
|
pallium development
|
GO:0021543 |
120 |
0.017
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.017
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.017
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.017
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.017
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.017
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.017
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.017
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.017
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.017
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.017
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.017
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.017
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.017
|
|
|
ear development
|
GO:0043583 |
200 |
0.016
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.016
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.016
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.016
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.016
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.016
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.016
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.016
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.016
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.016
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.016
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.016
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.016
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.016
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.016
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.016
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.016
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.016
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.016
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.016
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.016
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.016
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.016
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.016
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.016
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.016
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.016
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.016
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.016
|
|
|
tube closure
|
GO:0060606 |
91 |
0.016
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.016
|
|
|
positive regulation of dendritic cell chemotaxis
|
GO:2000510 |
1 |
0.016
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.015
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.015
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.015
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.015
|
|
|
insulin like growth factor receptor signaling pathway
|
GO:0048009 |
21 |
0.015
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.015
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.015
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.015
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.015
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.015
|
Mouse |
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.015
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.015
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.015
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.015
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.015
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.015
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.015
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.015
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.015
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.015
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.015
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.015
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.015
|
|
|
positive regulation of sodium ion transmembrane transport
|
GO:1902307 |
4 |
0.015
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.015
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.015
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.015
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.015
|
|
|
regulation of sodium ion export from cell
|
GO:1903276 |
1 |
0.015
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.015
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.015
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.015
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.015
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.014
|
|
|
termination of rna polymerase i transcription
|
GO:0006363 |
2 |
0.014
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.014
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.014
|
Mouse |
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.014
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.014
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.014
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.014
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.014
|
|
|
heart growth
|
GO:0060419 |
45 |
0.014
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.014
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.014
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.014
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.014
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.014
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.014
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.014
|
|
|
skin development
|
GO:0043588 |
220 |
0.014
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
18 |
0.014
|
|
|
negative regulation of growth of symbiont in host
|
GO:0044130 |
19 |
0.014
|
Mouse |
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.014
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.014
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.014
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.014
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.014
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.014
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.014
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.014
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.014
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.014
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.014
|
|
|
limb development
|
GO:0060173 |
166 |
0.014
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.014
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.014
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.014
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.014
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.014
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.014
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.014
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.014
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.014
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.014
|
Mouse |
|
extracellular structure organization
|
GO:0043062 |
148 |
0.014
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.013
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.013
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.013
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.013
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.013
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.013
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.013
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.013
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.013
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.013
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.013
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.013
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.013
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.013
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.013
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.013
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.013
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.013
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.013
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.013
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.013
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.013
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.013
|
|